Your browser doesn't support javascript.
loading
A risk score for predicting hospitalization for community-acquired pneumonia in ITP using nationally representative data.
Wu, Ye-Jun; Hou, Ming; Liu, Hui-Xin; Peng, Jun; Ma, Liang-Ming; Yang, Lin-Hua; Feng, Ru; Liu, Hui; Liu, Yi; Feng, Jia; Zhang, Hong-Yu; Zhou, Ze-Ping; Wang, Wen-Sheng; Shen, Xu-Liang; Zhao, Peng; Fu, Hai-Xia; Zeng, Qiao-Zhu; Wang, Xing-Lin; Huang, Qiu-Sha; He, Yun; Jiang, Qian; Jiang, Hao; Lu, Jin; Zhao, Xiang-Yu; Zhao, Xiao-Su; Chang, Ying-Jun; Xu, Lan-Ping; Li, Yue-Ying; Wang, Qian-Fei; Zhang, Xiao-Hui.
Afiliação
  • Wu YJ; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.
  • Hou M; Collaborative Innovation Center of Hematology, Peking University, Beijing, China.
  • Liu HX; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
  • Peng J; National Clinical Research Center for Hematologic Disease, Beijing, China.
  • Ma LM; Department of Hematology, Qilu Hospital, Shandong University, Jinan, China.
  • Yang LH; Department of Clinical Epidemiology and Biostatistics, Peking University People's Hospital, Beijing, China.
  • Feng R; Department of Hematology, Qilu Hospital, Shandong University, Jinan, China.
  • Liu H; Affiliated Shanxi Big Hospital of Shanxi Medical University, Taiyuan, China.
  • Liu Y; Department of Hematology, Second Affiliated Hospital of Shanxi Medical University, Taiyuan, China.
  • Feng J; Department of Hematology, Beijing Hospital, Ministry of Health, Beijing, China.
  • Zhang HY; Department of Hematology, Beijing Hospital, Ministry of Health, Beijing, China.
  • Zhou ZP; Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing, China.
  • Wang WS; Department of Hematology, Peking University Shenzhen Hospital, Shenzhen, China.
  • Shen XL; Department of Hematology, Peking University Shenzhen Hospital, Shenzhen, China.
  • Zhao P; Department of Hematology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
  • Fu HX; Department of Hematology, Peking University First Hospital, Beijing, China.
  • Zeng QZ; Department of Hematology, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, China.
  • Wang XL; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.
  • Huang QS; Collaborative Innovation Center of Hematology, Peking University, Beijing, China.
  • He Y; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
  • Jiang Q; National Clinical Research Center for Hematologic Disease, Beijing, China.
  • Jiang H; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.
  • Lu J; Collaborative Innovation Center of Hematology, Peking University, Beijing, China.
  • Zhao XY; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
  • Zhao XS; National Clinical Research Center for Hematologic Disease, Beijing, China.
  • Chang YJ; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.
  • Xu LP; Collaborative Innovation Center of Hematology, Peking University, Beijing, China.
  • Li YY; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
  • Wang QF; National Clinical Research Center for Hematologic Disease, Beijing, China.
  • Zhang XH; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.
Blood Adv ; 4(22): 5846-5857, 2020 11 24.
Article em En | MEDLINE | ID: mdl-33232474
ABSTRACT
Infection is one of the primary causes of death from immune thrombocytopenia (ITP), and the lungs are the most common site of infection. We identified the factors associated with hospitalization for community-acquired pneumonia (CAP) in nonsplenectomized adults with ITP and established the [corrected] (ACPA) prediction model to predict the incidence of hospitalization for CAP. This was a retrospective study of nonsplenectomized adult patients with ITP from 10 large medical centers in China. The derivation cohort included 145 ITP inpatients with CAP and 1360 inpatients without CAP from 5 medical centers, and the validation cohort included the remaining 63 ITP inpatients with CAP and 526 inpatients without CAP from the other 5 centers. The 4-item ACPA model, which included age, Charlson Comorbidity Index score, initial platelet count, and initial absolute lymphocyte count, was established by multivariable analysis of the derivation cohort. Internal and external validation were conducted to assess the performance of the model. The ACPA model had an area under the curve of 0.853 (95% confidence interval [CI], 0.818-0.889) in the derivation cohort and 0.862 (95% CI, 0.807-0.916) in the validation cohort, which indicated the good discrimination power of the model. Calibration plots showed high agreement between the estimated and observed probabilities. Decision curve analysis indicated that ITP patients could benefit from the clinical application of the ACPA model. To summarize, the ACPA model was developed and validated to predict the occurrence of hospitalization for CAP, which might help identify ITP patients with a high risk of hospitalization for CAP.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pneumonia / Púrpura Trombocitopênica Idiopática Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans País como assunto: Asia Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pneumonia / Púrpura Trombocitopênica Idiopática Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans País como assunto: Asia Idioma: En Ano de publicação: 2020 Tipo de documento: Article